On the other side, tumor-released VEGFA, semaphorin 3A and CXCL12 recruit TAMs in pre metastatic niches, where they suppress the cytotoxic activity of CD8+ T cells and promote recruitment of Treg cells [145]. The gene discussed is CD8A; the disease is neoplasm.